NZ220365A - Antiviral peptides and pharmaceutical compositions - Google Patents

Antiviral peptides and pharmaceutical compositions

Info

Publication number
NZ220365A
NZ220365A NZ220365A NZ22036587A NZ220365A NZ 220365 A NZ220365 A NZ 220365A NZ 220365 A NZ220365 A NZ 220365A NZ 22036587 A NZ22036587 A NZ 22036587A NZ 220365 A NZ220365 A NZ 220365A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
antiviral peptides
antiviral
peptides
pharmaceutical
Prior art date
Application number
NZ220365A
Inventor
Eric Aron Cohen
Pierette Gaudreau
Jacques Michaud
Paul Brazeau
Yves Langelier
Original Assignee
Eric Aron Cohen
Pierette Gaudreau
Jacques Michaud
Paul Brazeau
Yves Langelier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 530250 external-priority patent/CA1277901C/en
Application filed by Eric Aron Cohen, Pierette Gaudreau, Jacques Michaud, Paul Brazeau, Yves Langelier filed Critical Eric Aron Cohen
Publication of NZ220365A publication Critical patent/NZ220365A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ220365A 1986-05-20 1987-05-19 Antiviral peptides and pharmaceutical compositions NZ220365A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA509527 1986-05-20
CA 530250 CA1277901C (en) 1987-02-20 1987-02-20 Means for treating herpes infections

Publications (1)

Publication Number Publication Date
NZ220365A true NZ220365A (en) 1990-06-26

Family

ID=25671005

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ220365A NZ220365A (en) 1986-05-20 1987-05-19 Antiviral peptides and pharmaceutical compositions

Country Status (6)

Country Link
US (1) US4795740A (en)
EP (1) EP0246630B1 (en)
AU (1) AU602334B2 (en)
DE (1) DE3785388T2 (en)
ES (1) ES2054630T3 (en)
NZ (1) NZ220365A (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (en) * 1987-05-22 1990-08-22 Merck & Co. Inc. Inhibitor of ribonucleotide reductase
FR2620938B3 (en) * 1987-09-30 1990-01-05 Bontemps Raymond NEW DEVICE FOR STORING FROZEN COSMETIC SUBSTANCES
CA1302887C (en) * 1987-11-24 1992-06-09 Yves Langelier Combination of acyclovir or a derivative thereof and bacitracin
CA1327869C (en) * 1989-02-17 1994-03-15 Yvan Guindon Ribonucleotide reductase inhibitors
ATE123294T1 (en) * 1989-07-07 1995-06-15 Bio Mega Boehringer Ingelheim ANTIHERPES TETRAPEPTIDE DERIVATIVES WITH A SUBSTITUTED ASPARAGIC ACID SIDE CHAIN.
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
CA1340681C (en) * 1989-07-07 1999-07-27 Robert Deziel Antiherpes tetrapeptides having a substituted aspartic acid side chain
ATE118785T1 (en) * 1989-07-07 1995-03-15 Bio Mega Boehringer Ingelheim PENTAPEPTIDE DERIVATIVES, EFFECTIVE AGAINST HERPES, CONTAINING A REPLACED ASPARAGIC ACID SIDE CHAIN.
CA1340684C (en) * 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides
CA1340683C (en) * 1989-07-07 1999-07-27 Pierre Louis Beaulieu Antiherpes pentapeptides having a substituted aspartic acid side chain
US5110799A (en) * 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
US5648337A (en) * 1990-07-03 1997-07-15 Bio-Mega/Boehringer Ingelheim Research Inc. Antiherpes pentapeptides
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
US5574015A (en) * 1992-03-12 1996-11-12 Bio-Mega/Boehringer Ingelheim Research Inc. Isosteric antiherpes peptide derivatives
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
DE69320390T2 (en) 1992-03-12 1999-02-11 Boehringer Ingelheim (Canada) Ltd., Laval, Quebec Isosteric peptide derivatives for herpes
IT1280157B1 (en) * 1995-04-12 1998-01-05 Consorzio Di Ricerche Biomedic PROCEDURE FOR THE PREPARATION AND STORAGE OF CELL CULTURES, OR PARTS OF CELLS, READY FOR DOSAGE
CA2152541C (en) * 1995-06-23 1998-12-15 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Herpes ribonucleotide reductase inhibitors
US5948935A (en) * 1997-01-23 1999-09-07 Boehringer Ingelheim (Canada) Ltd. Process and intermediates for (s)-α-amino-1-carboxycyclopentaneacetic acid
AU3079799A (en) * 1998-03-12 1999-09-27 Procter & Gamble Company, The Protease inhibitors in absorbent articles
EP1862471A3 (en) * 2000-02-07 2008-05-28 Wisconsin Alumni Research Foundation Pharmacologically active antiviral peptides and methods of their use
DE60130641T2 (en) * 2000-02-07 2008-06-26 Wisconsin Alumni Research Foundation, Madison PHARMACOLOGICALLY ACTIVE ANTIVIRAL PEPTIDES AND METHODS OF THEIR APPLICATION
ATE369427T1 (en) * 2001-03-22 2007-08-15 Us Health GLYCOSYLATION-RESISTANT CYANOVIRINS AND ASSOCIATED CONJUGATES, COMPOSITIONS, NUCLEIC ACIDS, VECTORS, HOST CELLS, PRODUCTION METHODS AND METHODS FOR USING NON-GLYCOSYLATED CYANOVIRINS
AU2002359792A1 (en) * 2001-12-18 2003-06-30 Proteologics, Inc. Methods and compositions for the inhibition of viral release
WO2005060541A2 (en) * 2003-12-01 2005-07-07 Wisconsin Alumni Research Foundation Peptides and methods for inducing cellular resistance to infection
PL227562B1 (en) 2011-09-23 2017-12-29 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Application of the bacitracin antibiotic for the hydrolytic degradation of RNA
ES2444299B1 (en) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Use of a casein hydrolyzate as an antiherpetic agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB185024A (en) * 1921-09-02 1922-08-31 Singer Mfg Co Motor driven sewing machine
US4126606A (en) * 1976-10-04 1978-11-21 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Physiologically active peptides and a process for preparation thereof
GB2062643B (en) * 1979-11-07 1983-04-07 Mckerns K W Contraceptive polypeptides
DE3100974A1 (en) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Medicaments having immunoregulating action which contain thymosin alpha 1 fragments, and thymosin alpha 1 fragments
FI83662C (en) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostic antibody and procedure for its preparation
IL65184A (en) * 1982-03-05 1985-08-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
DE3514587A1 (en) * 1985-04-23 1986-10-30 Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl PHARMACOLOGICALLY ACTIVE PEPTIDES
IE870507L (en) * 1986-03-07 1987-09-07 Biothechnological Res Partners Bovine virus diarrhea and hog cholera vaccines

Also Published As

Publication number Publication date
EP0246630B1 (en) 1993-04-14
EP0246630A2 (en) 1987-11-25
DE3785388D1 (en) 1993-05-19
DE3785388T2 (en) 1993-09-02
EP0246630A3 (en) 1989-01-04
ES2054630T3 (en) 1994-08-16
AU7321087A (en) 1987-11-26
US4795740A (en) 1989-01-03
AU602334B2 (en) 1990-10-11

Similar Documents

Publication Publication Date Title
NZ220365A (en) Antiviral peptides and pharmaceutical compositions
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
GB2196964B (en) Pharmaceutical compositions
NZ222133A (en) N #alpha# -(#alpha#-glucosyl(1-4)-deoxyfructosyl)-octreotide and pharmaceutical compositions
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
GB8608818D0 (en) Pharmaceutical compositions
IL84268A (en) Amino-cyclohexyl-hydroxyalkanoic acid peptide derivatives and pharmaceutical compositions containing them
GB8618259D0 (en) Pharmaceutical compositions
IL82146A0 (en) Liposomes based on phosphatidyl-inositolmannosides and pharmaceutical compositions containing them
GB2191696B (en) Pharmaceutical compositions
GB2190838B (en) Pharmaceutical compositions
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
GB8629781D0 (en) Pharmaceutical compositions
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ219250A (en) Purine derivatives and pharmaceutical compositions
GB2188235B (en) Pharmaceutical compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions